| Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1 EC Hsu, MA Rice, A Bermudez, FJG Marques, M Aslan, S Liu, ... Proceedings of the National Academy of Sciences 117 (4), 2032-2042, 2020 | 107 | 2020 |
| LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis SQ Liu, ZY Zhou, X Dong, L Guo, KJ Zhang Bioscience reports 40 (7), BSR20200626, 2020 | 47 | 2020 |
| Plectin is a regulator of prostate cancer growth and metastasis M Buckup, MA Rice, EC Hsu, F Garcia-Marques, S Liu, M Aslan, ... Oncogene 40 (3), 663-676, 2021 | 37 | 2021 |
| Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients Y Hu, M Wang, Y Chen, X Chen, F Fang, S Liu, Y Zhang Chinese medical journal 127 (15), 2765-2770, 2014 | 34 | 2014 |
| Engineering polysaccharide‐based hydrogel photonic constructs: from multiscale detection to the biofabrication of living optical fibers CF Guimarães, R Ahmed, A Mataji‐Kojouri, F Soto, J Wang, S Liu, ... Advanced Materials 33 (52), 2105361, 2021 | 26 | 2021 |
| Oncogene-mediated metabolic gene signature predicts breast cancer outcome M Aslan, EC Hsu, FJ Garcia-Marques, A Bermudez, S Liu, M Shen, ... NPJ Breast Cancer 7 (1), 141, 2021 | 26 | 2021 |
| Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer S Liu, M Shen, EC Hsu, CA Zhang, F Garcia-Marques, R Nolley, K Koul, ... British journal of cancer 124 (5), 896-900, 2021 | 25 | 2021 |
| Molecular mechanisms underlying the development of neuroendocrine prostate cancer S Liu, BR Alabi, Q Yin, T Stoyanova Seminars in Cancer Biology 86, 57-68, 2022 | 24 | 2022 |
| SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer MA Rice, V Kumar, D Tailor, FJ Garcia-Marques, EC Hsu, S Liu, ... Cell Reports Medicine 3 (2), 2022 | 21 | 2022 |
| MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer EC Hsu, M Shen, M Aslan, S Liu, M Kumar, F Garcia-Marques, ... Scientific Reports 11 (1), 13305, 2021 | 21 | 2021 |
| Current and emerging therapies for neuroendocrine prostate cancer BR Alabi, S Liu, T Stoyanova Pharmacology & Therapeutics 238, 108255, 2022 | 20 | 2022 |
| The role of Trop2 in prostate cancer: An oncogene, biomarker, and therapeutic target M Shen, S Liu, T Stoyanova American journal of clinical and experimental urology 9 (1), 73, 2021 | 20 | 2021 |
| Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay S Liu, F Garcia-Marques, CA Zhang, JJ Lee, R Nolley, M Shen, EC Hsu, ... Scientific reports 11 (1), 7612, 2021 | 19 | 2021 |
| Volbots: Volvox Microalgae‐Based Robots for Multimode Precision Imaging and Therapy J Wang, F Soto, S Liu, Q Yin, E Purcell, Y Zeng, EC Hsu, D Akin, B Sinclair, ... Advanced Functional Materials 32 (50), 2201800, 2022 | 18 | 2022 |
| Circular RNA circHIPK3 promotes breast cancer progression via sponging MiR-326 N Luo, S Liu, X Li, Y Hu, K Zhang Cell Cycle 20 (13), 1320-1333, 2021 | 18 | 2021 |
| The Significance of Abnormal Plasma Cell Clone in Bone Marrow of Primary Systemic Light Chain Amyloidosis Patients Y Hu, M Wang, Y Chen, X Chen, F Fang, L Shiqin, Y Zhang, X Wu, P Zhu Blood 122 (21), 5342, 2013 | 18 | 2013 |
| Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assay M Aslan, EC Hsu, S Liu, T Stoyanova Biology Methods and Protocols 6 (1), bpab014, 2021 | 17 | 2021 |
| Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway F Bai, C Wang, X Liu, D Hollern, S Liu, C Fan, C Liu, S Ren, ... Cell Death & Disease 13 (3), 195, 2022 | 13 | 2022 |
| Loss of function of GATA3 induces basal-like mammary tumors F Bai, C Zheng, X Liu, HL Chan, S Liu, J Ma, S Ren, WG Zhu, XH Pei Theranostics 12 (2), 720, 2022 | 13 | 2022 |
| p16INK4a suppresses BRCA1-deficient mammary tumorigenesis A Scott, F Bai, HL Chan, S Liu, J Ma, JM Slingerland, DJ Robbins, ... Oncotarget 7 (51), 84496, 2016 | 13 | 2016 |
